認知機能評価およびトレーニング市場-世界の市場規模、シェア、動向分析2014-2019と2030年までの予測

レポートナンバー　0000032525

認知機能評価およびトレーニング市場-世界の市場規模、シェア、動向分析2014-2019と2030年までの予測

Fatpos Global

Cognitive Assessment and Training Market: - Analysis of Market Size, Share & Trends for 2014 - 2019 and Forecasts to 2030

発刊日 2022/05

言語英語

体裁Word-PDF/171ページ

ライセンス/価格171ページ

0000032525

Single	4,950USD
Global Site License	6,550USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。Word-PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

認知機能評価およびトレーニング市場：市場セグメント：コンポーネント別（ソリューションおよびサービス）;組織規模別（大企業、および中小企業（SME））;用途別（臨床試験、学習、および研究）;業種別（BFSI、小売、IT＆テレコム、教育、ヘルスケア、その他）;地域別- 2014〜2019年の市場規模、シェア、動向分析、および2030年までの予測

市場概要
認知機能評価およびトレーニング市場は、予測期間、つまり2019-30年の間に、2018年の31億ドルから2030年までに123億ドルを超え、CAGRは29.7％になる見込みです。認知機能評価およびトレーニング市場の成長を促すもう1つの主な要因は、脳の健康に対する意識の高まりです。市場の前向きな見通しを生み出す重要な要因の1つは、世界中の電子産業の大幅な成長です。さらに、ほとんどの先進国および発展途上国では、ITシステムおよび医療技術の進歩が、認知機能評価ソリューションの成長を促進する上で重要な役割を果たしています。新世代のヘルスケアシステムとITソリューションの自然な拡張として、モバイルヘルス技術の開発が浮上しています。これらの要因が世界の認知機能評価およびトレーニング市場を後押ししています。

レポート詳細

12. Global Hypodermic Needles Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S., Mexico, and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Australia, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Saudi Arabia, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Non-Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Drug Delivery, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Vaccination, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Blood Specimen Collection, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. End User: Market Share (2020-2031F)
12.4.1. Hospital, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Diabetic Patients, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Family Practitioners, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Psychiatry, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F

13. Company Profile
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. B. Braun Melsungen Ag
13.3. Cardinal Health Inc.
13.4. Connecticut Hypodermics Inc.
13.5. Exelint International Co.
13.6. Mckesson Corporation
13.7. Hitech Syringes
13.8. Retractable Technologies, Inc.
13.9. Nipro Corporation
13.10. Terumo Medical Corporation
13.11. Other Prominent Players

14. Consultant Recommendation

15. The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the inal deliverable.
Contents

1. Executive Summary

2. Antimicrobial Susceptibility Testing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8. Recent Development, Policies & Regulatory Landscape

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Antimicrobial Susceptibility Testing Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11. Antimicrobial Susceptibility Testing Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. Antimicrobial Susceptibility Testing: Market Segmentation
12.1. By Regions
12.1.1. North America: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Manual Antimicrobial Susceptibility Testing Products, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Automated Laboratory Instruments, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Culture and Growth Media, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By Type: Market Share (2020-2030F)
12.3.1. Antibacterial Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Antifungal Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Antiparasitic Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Diagnostics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Drug Discovery and Development, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Epidemiology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5. By End User: Market Share (2020-2030F)
12.5.1. Hospitals and Diagnostic Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.2. Pharmaceutical and Biotechnology Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.3. Research &Academic Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.4. Clinical Research Organizations (CROs), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. Company Profile

14. Bio-Rad Laboratories, Inc
14.1. Company Overview
14.2. Company Total Revenue (Financials)
14.3. Market Potential
14.4. Global Presence
14.5. Key Performance Indicators
14.6. SWOT Analysis
14.7. Product Launch

15. Alifax

16. Becton Dickinson, and Company

17. Creative Diagnostics

18. Resistell AG

19. Danaher Corporation

20. Thermo Fisher Scientific Inc

21. Merck KGaA
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Contents

1. Executive Summary

2. Cognitive Assessment and Training Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8. Recent Development, Policies & Regulatory Landscape

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Cognitive Assessment and Training Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11. Cognitive Assessment and Training Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. Cognitive Assessment and Training: Market Segmentation
12.1. By Regions
12.1.1. North America: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Component: Market Share (2020-2030F)
12.2.1. Solutions, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By Organization Size: Market Share (2020-2030F)
12.3.1. Large Enterprises, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. SMEs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Clinical Trials, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Learning, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Research, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5. By Vertical: Market Share (2020-2030F)
12.5.1. BFSI, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.2. Retail, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.3. IT and Telecom, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.4. Education, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.5. Healthcare, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. Company Profile

14. Cambridge Cognition Ltd
14.1. Company Overview
14.2. Company Total Revenue (Financials)
14.3. Market Potential
14.4. Global Presence
14.5. Key Performance Indicators
14.6. SWOT Analysis
14.7. Product Launch

15. Cogstate Ltd.

16. MedAvante, Inc.

17. ProPhase, LLC

18. Neurocog Trials, Inc.

19. Medavante, Inc.

20. Quest Diagnostics, Inc.

21. ProPhase, LLC

22. Eresearchtechnology Inc.

23. Gompf Brackets, Inc

Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000032525

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。